GNOM
http://www.pharmpro.com/News/FeedsAP/2012/07/pluristem-poised-to-benefit-from-the-evolution-of-/
Resumen:
Another example of a company with cutting edge technology is Complete Genomics Inc. (NASDAQ:GNOM), which develops and commercializes a DNA sequencing platform for human genome sequencing and analysis. Its Complete Genomics Analysis platform combines its proprietary human genome sequencing technology with informatics and data management software to provide customers with data that is ready to be used for genome-based research.
GNOM also shows promise in a different segment from stem cell treatments, but like StemCells Inc., it burns far too much cash and also may have to engage in a secondary offering soon. In fact, from its last 10k, the company flatly states that they are running out of money.